3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 1
1
Status
Completed
12
Recruiting
8
Terminated
6
Unknown
3
Not yet recruiting
3
Withdrawn
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Observational
10
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
1275
Carcinoma, Non-Small-Cell Lung
783
Neoplasms
767
Colorectal Neoplasms
755
Carcinoma, Hepatocellular
579
Stomach Neoplasms
578
Prostatic Neoplasms
501
Lung Neoplasms
461
Pancreatic Neoplasms
416
Rectal Neoplasms
331
Recurrence
312
Neoplasm Metastasis
305
Leukemia, Myeloid, Acute
289
Multiple Myeloma
281
Colonic Neoplasms
280
Lymphoma
273
Uterine Cervical Neoplasms
269
Esophageal Neoplasms
267
Ovarian Neoplasms
261
Head and Neck Neoplasms
246
Melanoma
240
Precursor Cell Lymphoblastic Leukemia-Lymphoma
209
Brain Neoplasms
195
Lymphoma, Large B-Cell, Diffuse
184
Nasopharyngeal Carcinoma
180
Lymphoma, Non-Hodgkin
173
Leukemia
173
Liver Neoplasms
163
Glioblastoma
158
Urinary Bladder Neoplasms
153
Interventions
palbociclib
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Interventional
×
Thrombosis
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled
NCT05870449
2023-05-23
PICC
Shandong Branden Med.Device Co.,Ltd
Phase NA
Unknown
1,666 enrolled
NCT05067153
2021-10-05
TOP-RCT
University of Aarhus
Phase 4
Unknown
100 enrolled